{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:27:44Z","timestamp":1765758464379},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10571-017-0470-8","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T11:55:43Z","timestamp":1488974143000},"page":"1399-1405","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients"],"prefix":"10.1007","volume":"37","author":[{"given":"Jingjuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guode","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuohang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,8]]},"reference":[{"key":"470_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","volume":"72","author":"L Brattstrom","year":"2000","unstructured":"Brattstrom L, Wilcken DE (2000) Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72:315\u2013323","journal-title":"Am J Clin Nutr"},{"key":"470_CR2","first-page":"146","volume":"43","author":"CMA","year":"2010","unstructured":"CMA (2010) Editor team on treatment guidelines of acute ischemic stroke from Cerebrovascular Diseases Study Group in neurology branch of Chinese Medical Association. China acute ischemic stroke treatment guidelines. J Neurol 43:146\u2013153","journal-title":"J Neurol"},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","volume":"36","author":"E Coll","year":"2000","unstructured":"Coll E et al (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29\u201334. doi: 10.1053\/ajkd.2000.8237","journal-title":"Am J Kidney Dis"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2007.09.029","volume":"198","author":"R Cui","year":"2008","unstructured":"Cui R et al (2008) Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 198:412\u2013418. doi: 10.1016\/j.atherosclerosis.2007.09.029","journal-title":"Atherosclerosis"},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/01.wnl.0000435550.83200.9e","volume":"81","author":"H Gensicke","year":"2013","unstructured":"Gensicke H et al (2013) IV thrombolysis and renal function. Neurology 81:1780\u20131788. doi: 10.1212\/01.wnl.0000435550.83200.9e","journal-title":"Neurology"},{"key":"470_CR6","first-page":"1775","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM et al (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project JAMA 277:1775\u20131781","journal-title":"The European Concerted Action Project JAMA"},{"key":"470_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/jren.2001.24360","volume":"11","author":"H Han","year":"2001","unstructured":"Han H et al (2001) Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. J Ren Nutr 11:149\u2013154","journal-title":"J Ren Nutr"},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.02.020","volume":"234","author":"J Helmersson-Karlqvist","year":"2014","unstructured":"Helmersson-Karlqvist J, Arnlov J, Carlsson AC, Harma J, Larsson A (2014) Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort. Atherosclerosis 234:108\u2013113. doi: 10.1016\/j.atherosclerosis.2014.02.020","journal-title":"Atherosclerosis"},{"key":"470_CR9","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"C Homocysteine Studies","year":"2002","unstructured":"Homocysteine Studies C (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015\u20132022","journal-title":"JAMA"},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo Y et al (2015) Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325\u20131335. doi: 10.1001\/jama.2015.2274","journal-title":"JAMA"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJMe1308505","volume":"369","author":"JR Ingelfinger","year":"2013","unstructured":"Ingelfinger JR, Marsden PA (2013) Estimated GFR and risk of death\u2013is cystatin C useful? N Engl J Med 369:974\u2013975. doi: 10.1056\/NEJMe1308505","journal-title":"N Engl J Med"},{"key":"470_CR12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/1567202612666150807112205","volume":"12","author":"Y Ji","year":"2015","unstructured":"Ji Y et al (2015) Prognostic significance of homocysteine levels in acute ischemic stroke: a prospective cohort study. Curr Neurovasc Res 12:334\u2013340","journal-title":"Curr Neurovasc Res"},{"key":"470_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-004-0097-3","volume":"6","author":"DK Kalra","year":"2004","unstructured":"Kalra DK (2004) Homocysteine and cardiovascular disease. Curr Atheroscler Rep 6:101\u2013106","journal-title":"Curr Atheroscler Rep"},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ejim.2014.09.007","volume":"25","author":"NV Leach","year":"2014","unstructured":"Leach NV et al (2014) Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. Eur J Intern Med 25:762\u2013767. doi: 10.1016\/j.ejim.2014.09.007","journal-title":"Eur J Intern Med"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/01.STR.0000086753.00555.0D","volume":"34","author":"Z Li","year":"2003","unstructured":"Li Z et al (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case\u2013control study in china. Stroke 34:2085\u20132090. doi: 10.1161\/01.STR.0000086753.00555.0D","journal-title":"Stroke"},{"key":"470_CR16","first-page":"614","volume":"39","author":"JP Li","year":"2007","unstructured":"Li JP, Huo Y, Liu P (2007) Efficacy and safety of Enalapril-Folate acid tablets in lowering blood pressure and plasma homocysteine. Beijing Da Xue Xue Bao 39:614\u2013618","journal-title":"Beijing Da Xue Xue Bao"},{"key":"470_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/00365599.2011.639032","volume":"46","author":"D Liu","year":"2012","unstructured":"Liu D, Ding H, Liu S, Shen J (2012) Estimated glomerular filtration rate decline in 567 patients with acute stroke. Scand J Urol Nephrol 46:142\u2013147. doi: 10.3109\/00365599.2011.639032","journal-title":"Scand J Urol Nephrol"},{"key":"470_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/dc13-1931","volume":"37","author":"Y Luo","year":"2014","unstructured":"Luo Y et al (2014) Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. Diabetes Care 37:173\u2013179. doi: 10.2337\/dc13-1931","journal-title":"Diabetes Care"},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000356086","volume":"36","author":"A Power","year":"2013","unstructured":"Power A (2013) Stroke in dialysis and chronic kidney disease. Blood Purif 36:179\u2013183. doi: 10.1159\/000356086","journal-title":"Blood Purif"},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/01.STR.0000142374.33919.92","volume":"35","author":"RL Sacco","year":"2004","unstructured":"Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC (2004) Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern MAnhattan Study. Stroke 35:2263\u20132269. doi: 10.1161\/01.STR.0000142374.33919.92","journal-title":"Stroke"},{"key":"470_CR21","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"RL Sacco","year":"2006","unstructured":"Sacco RL et al (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113:e409\u2013e449","journal-title":"Circulation"},{"key":"470_CR22","first-page":"126","volume":"2","author":"F Saeed","year":"2009","unstructured":"Saeed F, Kousar N, Qureshi K, Laurence TN (2009) A review of risk factors for stroke in patients with chronic kidney disease. J Vasc Interv Neurol 2:126\u2013131","journal-title":"J Vasc Interv Neurol"},{"key":"470_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-1241.2001.tb11030.x","volume":"55","author":"PK Sarkar","year":"2001","unstructured":"Sarkar PK, Lambert LA (2001) Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke. Int J Clin Pract 55:262\u2013268","journal-title":"Int J Clin Pract"},{"key":"470_CR24","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1515\/CCLM.2003.214","volume":"41","author":"O Stanger","year":"2003","unstructured":"Stanger O et al (2003) DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392\u20131403. doi: 10.1515\/CCLM.2003.214","journal-title":"Clin Chem Lab Med"},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1515\/CCLM.2001.122","volume":"39","author":"ME Suliman","year":"2001","unstructured":"Suliman ME, Lindholm B, Barany P, Bergstrom J (2001) Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 39:734\u2013738. doi: 10.1515\/CCLM.2001.122","journal-title":"Clin Chem Lab Med"},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"JF Toole","year":"2004","unstructured":"Toole JF et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291:565\u2013575. doi: 10.1001\/jama.291.5.565","journal-title":"JAMA"},{"key":"470_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2010.07.013","volume":"298","author":"A Towfighi","year":"2010","unstructured":"Towfighi A, Markovic D, Ovbiagele B (2010) Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci 298:153\u2013157. doi: 10.1016\/j.jns.2010.07.013","journal-title":"J Neurol Sci"},{"key":"470_CR28","first-page":"473","volume":"114","author":"PM Ueland","year":"1989","unstructured":"Ueland PM, Refsum H (1989) Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 114:473\u2013501","journal-title":"J Lab Clin Med"},{"key":"470_CR29","first-page":"11174","volume":"8","author":"H Wang","year":"2015","unstructured":"Wang H, Cui K, Xu K, Xu S (2015) Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients Int J. Clin Exp Med 8:11174\u201311180","journal-title":"Clin Exp Med"},{"key":"470_CR30","first-page":"976","volume":"47","author":"X Xu","year":"2008","unstructured":"Xu X (2008) Effective control of H-type hypertension: new ideas for stroke prevention. Chin J Integr Med 47:976\u2013977","journal-title":"Chin J Integr Med"},{"key":"470_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/STROKEAHA.108.520882","volume":"40","author":"G Yahalom","year":"2009","unstructured":"Yahalom G et al (2009) Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 40:1296\u20131303. doi: 10.1161\/STROKEAHA.108.520882","journal-title":"Stroke"},{"key":"470_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1042\/CS20090142","volume":"118","author":"W Zhang","year":"2010","unstructured":"Zhang W et al (2010) High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci (Lond) 118:187\u2013194. doi: 10.1042\/CS20090142","journal-title":"Clin Sci (Lond)"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-017-0470-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-017-0470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-017-0470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:49:11Z","timestamp":1692715751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-017-0470-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1007\/s10571-017-0470-8","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,8]]}}}